Diabetes, Vol 48, Issue 9 1741-1746, Copyright © 1999 by American Diabetes Association

ARTICLES

Corticotropin-releasing factor modulation of Ca2+ influx in rat pancreatic beta-cells

T Kanno, S Suga, K Nakano, N Kamimura and M Wakui
Department of Physiology, Hirosaki University School of Medicine, Japan. tkanno@cc.hirosaki-u.ac.jp

The effects of corticotropin-releasing factor (CRF) on the intracellular concentration of Ca2+ were studied in isolated single beta-cells of the rat islet. Immunohistochemical staining using CRF-receptor antibodies revealed the presence of both type 1 (CRF-R1) and type 2 (CRF-R2) receptors for CRF in the majority of islet cells. CRF (2 nmol/l) increased cytosolic Ca2+ concentration under 2.8 mmol/l glucose, dependent upon extracellular Ca2+. CRF caused depolarization of the cell membrane, which was followed by action potentials under 2.8 mmol/l glucose. The dose-response relationships of CRF-induced depolarization in the presence of 1 micromol/l nifedipine produced a bell-shaped curve, showing the peak response at 2 nmol/l. In the whole-cell patch-clamp recording, CRF enhanced Ca2+ currents through L-type Ca2+ channels in a dose-dependent manner similar to that for depolarization. In cells pretreated with Rp-deastereomer of adenosine cyclic 3',5'-phosphorothiolate (100 micromol/l), neither depolarization nor an increase in the Ca2+ current was caused by CRF at concentrations <2 nmol/l. In these cells, CRF at 20 nmol/l reduced the Ca2+ current. These results suggest that in single beta-cells of rat islets, CRF, through its own receptor, potentiates Ca2+ influx through the L-type Ca2+ channel by activation of the cAMP/protein kinase A signaling pathway. CRF at a high concentration also shows an inhibitory effect on the Ca2+ current through an unknown signaling pathway.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				X.-Q. Chen, J. Dong, C.-Y. Niu, J.-M. Fan, and J.-Z. Du Effects of Hypoxia on Glucose, Insulin, Glucagon, and Modulation by Corticotropin-Releasing Factor Receptor Type 1 in the Rat Endocrinology, July 1, 2007; 148(7): 3271 - 3278. [Abstract] [Full Text] [PDF]

				C. Li, P. Chen, J. Vaughan, K.-F. Lee, and W. Vale Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis PNAS, March 6, 2007; 104(10): 4206 - 4211. [Abstract] [Full Text] [PDF]

				E. Bertelli and M. Bendayan Association between Endocrine Pancreas and Ductal System. More than an Epiphenomenon of Endocrine Differentiation and Development? J. Histochem. Cytochem., September 1, 2005; 53(9): 1071 - 1086. [Abstract] [Full Text] [PDF]

				C. Li, P. Chen, J. Vaughan, A. Blount, A. Chen, P. M. Jamieson, J. Rivier, M. S. Smith, and W. Vale Urocortin III Is Expressed in Pancreatic {beta}-Cells and Stimulates Insulin and Glucagon Secretion Endocrinology, July 1, 2003; 144(7): 3216 - 3224. [Abstract] [Full Text] [PDF]

				K. Nakano, S. Suga, T. Takeo, Y. Ogawa, T. Suda, T. Kanno, and M. Wakui Intracellular Ca2+ Modulation of ATP-Sensitive K+ Channel Activity in Acetylcholine-Induced Activation of Rat Pancreatic {beta}-Cells Endocrinology, February 1, 2002; 143(2): 569 - 576. [Abstract] [Full Text] [PDF]

				Y. Tsubamoto, K. Eto, M. Noda, S. Daniel, S. Suga, S. Yamashita, H. Kasai, M. Wakui, G. W. G. Sharp, S. Kimura, et al. Hexamminecobalt(III) Chloride Inhibits Glucose-induced Insulin Secretion at the Exocytotic Process J. Biol. Chem., January 26, 2001; 276(5): 2979 - 2985. [Abstract] [Full Text] [PDF]